¸²ÇÁÁ¾ Áúȯ Àü¹®, ¼¼Æ÷Ä¡·á Ȱ¹ßÈ÷ ¿¬±¸
| Á¦ ¸ñ | Efficacy of ex vivo purging with CD34+selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | CYTOTHERAPY |
| Á¦ ¸ñ | Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | FRONTIERS IN ONCOLOGY |
| Á¦ ¸ñ | The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | SCIENTIFIC REPORTS |
| Á¦ ¸ñ | Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | DIAGNOSTICS |
| Á¦ ¸ñ | A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | EXPERT OPINION ON BIOLOGICAL THERAPY |
| Á¦ ¸ñ | Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | ANNALS OF HEMATOLOGY |
| Á¦ ¸ñ | Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | CANCER MEDICINE |

°¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº 1980³â °³² Áö¿ª ÃÖÃÊÀÇ Á¾ÇÕº´¿øÀ¸·Î ¼¼¿öÁ³´Ù. ÇöÀç Áö»ó 22Ãþ, ÁöÇÏ 6ÃþÀÇ 1355º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖÀ¸¸ç ´ÜÀÏ °Ç¹° º´¿øÀ¸·Î´Â ±¹³» ÃÖ´ë ±Ô¸ðÀÌ´Ù. °¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº °¡Å縯±³È¸ÀÇ ´ëÇ¥ º´¿øÀ¸·Î °¡Å縯Áß¾ÓÀÇ·á¿øÀÇ ÀÌ³ä ½Çõ¿¡ Àû±Ø ¾ÕÀå¼°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ ¸ÕÀú »ý°¢ÇÏ´Â Àü¹®¼¾ÅÍ Áß½ÉÀÇ º´¿ø, 21¼¼±â ÃÖ÷´Ü ÀÇ·á ½Ã½ºÅÛ º´¿øÀ¸·Î °Åµì³ª°í ÀÖ´Ù.
¼¿ïƯº°½Ã ¼Ãʱ¸ ¹ÝÆ÷´ë·Î 222